Beeness Biotech LP is a private equity fund based in Lewes, Delaware. Its most recent Form D, filed Feb 16, 2022, reports no sales yet. The minimum investment it accepts from an outside investor is $50,000. The offering uses Rule 506(c), which permits general advertising to investors verified as accredited. Related persons named in the filing include Marcelo Callegari.
- Total raised
- $0Cumulative sales reported on Form D
- Investors
- 0
- First sale
- —
- Minimum investment
- $50,000
- Who can invest
- Not stated
- Offering exemption
- Rule 506(c)May advertise; investors must be verified as accredited
- Key people and entities
- Marcelo Callegari
- Latest Form D
- Feb 16, 2022
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Beeness Biotech LP
What is the minimum investment for Beeness Biotech LP?
According to its latest Form D, filed Feb 16, 2022, the minimum investment Beeness Biotech LP accepts from an outside investor is $50,000.
Who can invest in Beeness Biotech LP?
Beeness Biotech LP is generally open only to investors who meet the eligibility rules in its offering documents. It uses Rule 506(c), so it may advertise, but every investor must be verified as accredited.
How much has Beeness Biotech LP raised?
Beeness Biotech LP's latest Form D, filed Feb 16, 2022, reports no sales yet.
Where is Beeness Biotech LP based?
Beeness Biotech LP is based in Lewes, Delaware.
Size compared with every private equity fund
This fund hasn't reported any sales yet.